Hillman Ventures

About Hillman Ventures.

Family office, Dallas, Founded 1995

Hillman Ventures is a private family office in Dallas, Texas, founded in 1995 by Andrew Jonathan Hillman. It invests its own capital in FDA-regulated biotechnology, with a focus on inflammation, damaged tissue and tumor-based cancers. It does not manage outside money. Its activities and holdings are kept private by design.

Key facts.

Name
Hillman Ventures (also written HillmanV)
Type
Private family office
Founded
1995
Based
Dallas, Texas
Principal
Andrew Jonathan Hillman (Andrew J. Hillman)
Focus
Frontier biotech for inflammation, damaged tissue and tumor-based cancers
Capital
Its own capital. It does not manage outside money.
Press and interviews
[email protected]

How does Hillman Ventures choose what to back?

Hillman Ventures backs frontier biotech for inflammation, damaged tissue and tumor-based cancers. Three principles guide the work: regulatory pathway first, capital discipline as the durable advantage, and relationships that compound. Position size scales with the quality of the evidence. The firm looks at the science, the manufacturing and the regulatory path to patients.

Who is the principal of Hillman Ventures?

Andrew Jonathan Hillman is the principal of Hillman Ventures. He spent three decades co-founding, operating and exiting FDA-regulated healthcare companies, with more than 89 ventures and more than 85 strategic exits. He writes The Hillman Letter on FDA regulatory strategy. His biography and official profiles are on andrew-hillman.com.

More answers: Who is Andrew Jonathan Hillman Biography Answers on the main site Hillman Ventures FAQ Ventures

Nothing on this site is an offer to sell or a solicitation of an offer to buy any security. Nothing on this site is investment advice.

Investigational status. Exosome, mesenchymal stem cell-derived extracellular vesicle, and Targeted Osmotic Lysis products referenced on this site are investigational and are not approved by the FDA for any indication. They are not available as a treatment.